Holding(s) in Company

RNS Number : 9191J

AstraZeneca PLC

18 June 2014

 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				AstraZeneca PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached					No
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments					No
An event changing the breakdown of voting rights					No
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		Invesco Limited
4. Full name of shareholder(s)  (if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v		17 April 2014
6. Date on which issuer notified:		17 June 2014
7. Threshold(s) that is/are crossed or reached: vi, vii		5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares

72,920,319

72,920,319

63,033,761

4.99%

GB0009895292

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

63,033,761

4.99%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Invesco Advisers Inc. - 182,047 Invesco Asset Management Japan - 75,034 Invesco Asset Management Limited - 16,790,150 Invesco Asset Management S.A (France) - 76,196 Invesco PowerShares Capital Management LLC - 158,278 Invesco GT Management Ltd - 39,146 Invesco Hong Kong Limited - 1,155 Invesco Fund Managers Limited - 45,006,926 Invesco Asset Management Limited GmbH - 667,087 Van Kampen Asset Management - 37,742
Proxy Voting:
10. Name of the proxy holder:		Invesco Limited
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:
14. Contact name:	Sam Edwards
15. Contact telephone number:	01491 416381

 

END

 

 

HOLGCGDLCGBBGSI